Your browser doesn't support javascript.
loading
An overlooked subset of Cx3cr1wt/wt microglia in the Cx3cr1CreER-Eyfp/wt mouse has a repopulation advantage over Cx3cr1CreER-Eyfp/wt microglia following microglial depletion.
Zhou, Kai; Han, Jinming; Lund, Harald; Boggavarapu, Nageswara Rao; Lauschke, Volker M; Goto, Shinobu; Cheng, Huaitao; Wang, Yuyu; Tachi, Asuka; Xie, Cuicui; Zhu, Keying; Sun, Ying; Osman, Ahmed M; Liang, Dong; Han, Wei; Gemzell-Danielsson, Kristina; Betsholtz, Christer; Zhang, Xing-Mei; Zhu, Changlian; Enge, Martin; Joseph, Bertrand; Harris, Robert A; Blomgren, Klas.
Afiliação
  • Zhou K; Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China. kai.zhou@ki.se.
  • Han J; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. kai.zhou@ki.se.
  • Lund H; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Boggavarapu NR; Neuroimmunology Center, Department of Neurology, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, China.
  • Lauschke VM; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Goto S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Cheng H; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Wang Y; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Tachi A; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Xie C; University of Tuebingen, Tuebingen, Germany.
  • Zhu K; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Sun Y; Department of Obstetrics and Gynecology, Nagoya City University Hospital, Nagoya, Japan.
  • Osman AM; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Liang D; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Han W; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Gemzell-Danielsson K; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Betsholtz C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Zhang XM; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Zhu C; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Enge M; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Joseph B; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Harris RA; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Blomgren K; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
J Neuroinflammation ; 19(1): 20, 2022 Jan 21.
Article em En | MEDLINE | ID: mdl-35062962
ABSTRACT

BACKGROUND:

Fluorescent reporter labeling and promoter-driven Cre-recombinant technologies have facilitated cellular investigations of physiological and pathological processes, including the widespread use of the Cx3cr1CreER-Eyfp/wt mouse strain for studies of microglia.

METHODS:

Immunohistochemistry, Flow Cytometry, RNA sequencing and whole-genome sequencing were used to identify the subpopulation of microglia in Cx3cr1CreER-Eyfp/wt mouse brains. Genetically mediated microglia depletion using Cx3cr1CreER-Eyfp/wtRosa26DTA/wt mice and CSF1 receptor inhibitor PLX3397 were used to deplete microglia. Primary microglia proliferation and migration assay were used for in vitro studies.

RESULTS:

We unexpectedly identified a subpopulation of microglia devoid of genetic modification, exhibiting higher Cx3cr1 and CX3CR1 expression than Cx3cr1CreER-Eyfp/wtCre+Eyfp+ microglia in Cx3cr1CreER-Eyfp/wt mouse brains, thus termed Cx3cr1highCre-Eyfp- microglia. This subpopulation constituted less than 1% of all microglia under homeostatic conditions, but after Cre-driven DTA-mediated microglial depletion, Cx3cr1highCre-Eyfp- microglia escaped depletion and proliferated extensively, eventually occupying one-third of the total microglial pool. We further demonstrated that the Cx3cr1highCre-Eyfp- microglia had lost their genetic heterozygosity and become homozygous for wild-type Cx3cr1. Therefore, Cx3cr1highCre-Eyfp- microglia are Cx3cr1wt/wtCre-Eyfp-. Finally, we demonstrated that CX3CL1-CX3CR1 signaling regulates microglial repopulation both in vivo and in vitro.

CONCLUSIONS:

Our results raise a cautionary note regarding the use of Cx3cr1CreER-Eyfp/wt mouse strains, particularly when interpreting the results of fate mapping, and microglial depletion and repopulation studies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Microglia Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Microglia Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article